Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
levonorgestrel and ethinyl estradiol
Medication labelWhy this: Advisory · dailymed-prescription
Jolessa™ tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. In a 1-year controlled clinical trial, 4 pregnancies occurred in women 18-35 years of age during 809 completed 91-day cycles of Jolessa™ during which no backup contraception was utilized. This represents an overall use-efficacy (typical user efficacy) pregnancy rate of 1.98 per 100 women-years of use. Oral contraceptives are highly effective for pregnancy prevention. Table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, the IUD, and Norplant® Implant System, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates.
- generic_name
- levonorgestrel and ethinyl estradiol
- brand_name
- INERT
- product_names
- levonorgestrel and ethinyl estradiol, INERT
- ndc
- 54868-6044, 0555-9123, 54868-6044-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en